- •Preface
- •Contents
- •1.1.1 The Vitreous
- •1.1.1.1 Embryology
- •1.1.1.2 The Anatomy
- •1.1.1.3 Anatomical Attachments of the Vitreous to the Surrounding Structures
- •1.1.2 The Retina
- •1.1.2.1 Embryology
- •1.1.2.2 Anatomy
- •Retinal Pigment Epithelium (RPE)
- •Photoreceptor Layer
- •Intermediary Neurones
- •Ganglion Cells
- •Retinal Blood Vessels
- •Other Fundal Structures
- •1.1.3 The Physiology of the Vitreous
- •1.2 Clinical Examination and Investigation
- •1.2.1 Using the Database
- •1.2.2 Examination of the Eye
- •1.2.2.1 Examination Technique
- •Visual Acuity
- •1.2.2.2 The Slit Lamp
- •1.2.2.3 Binocular Indirect Ophthalmoscope
- •1.2.2.4 Using the Indenter
- •1.2.2.5 Ultrasonography
- •Posterior Vitreous Detachment (PVD)
- •Retinal Tear
- •Retinal Detachment
- •Subretinal Haemorrhage
- •Retinoschisis
- •Choroidal Elevation
- •Trauma
- •1.2.2.6 Optical Coherence Tomography
- •Time-Domain OCT
- •Colour Coding
- •Frequency-Domain OCT
- •Full-Field OCT
- •Scan Resolution
- •Images and Measurements
- •Performing the Scan
- •Macular Scan Patterns
- •Central Retinal Thickness
- •Inner Segment and Outer Segment Junction and External Limiting Membrane
- •1.2.3 Subjective Tests
- •1.2.4 The Preoperative Assessment
- •1.3 Summary
- •References
- •2: Introduction to Vitreoretinal Surgery
- •2.1 Introduction
- •2.2 Choice of Anaesthesia
- •2.3 Pars Plana Vitrectomy
- •2.3.1 Sclerotomies
- •2.3.2 Where to Place the Sclerotomies
- •2.3.3 Securing the Infusion Cannula
- •2.3.4 Checking the Infusion
- •2.3.6 The Superior Sclerotomies
- •2.3.6.1 Where to Place
- •2.3.7 Checking the View
- •2.3.8 The Independent Viewing System
- •2.3.9 Removing the Vitreous
- •2.4 Vitrectomy Cutters
- •2.5 Handling the Light Pipe
- •2.6 Use of Sclerotomy Plugs
- •2.7 The Internal Search
- •2.8 Endolaser
- •2.9 Using a Contact Lens
- •2.10 Maintaining a View
- •2.10.1 Microscope
- •2.10.3 Cornea
- •2.10.4 Blood in the Anterior Chamber
- •2.10.5 Condensation on an Intraocular Lens Implant
- •2.10.6 Cataract Formation
- •2.10.7 Pupillary Dilation
- •2.11 Closing
- •2.12 Peroperative Complications
- •2.12.1 Iatrogenic Breaks
- •2.12.1.1 Causes
- •2.12.2 Choroidal Haemorrhage
- •2.12.3 Haemorrhage from Retinal or Other Blood Vessels
- •2.12.4 Lens Touch
- •2.12.5 Hypotony
- •2.13 Postoperative Complications
- •2.13.1 Cataract
- •2.13.2 Endophthalmitis
- •2.13.3 Corneal Changes
- •2.13.4 Choroidal Haemorrhage
- •2.13.5 Raised Intraocular Pressure
- •2.13.6 Retinal Breaks and RRD
- •2.13.7 Hypotony
- •2.13.8 Scleritis
- •2.13.9 Sympathetic Uveitis
- •2.14 Adjustments for 20 Gauge Vitrectomy
- •2.14.1 Construction of Superior Sclerotomies
- •2.14.2 Priming
- •2.14.3 Self-Sealing Sclerotomies
- •2.15 Adjustments for 23 and 25 Gauge Vitrectomy
- •2.15.1 Instrumentation
- •2.15.2 Surgical Technique
- •2.15.2.1 Vitrectomy Technique
- •2.15.3 Flexibility
- •2.15.4 Indentation
- •2.15.5 Flow Rates
- •2.15.6 Trochar Internal Protrusion
- •2.15.7 Silicone Oil
- •2.16 Complications
- •2.16.1 Peroperative
- •2.16.1.1 Extrusion of the Trochar on Removal of Instrumentation
- •2.16.1.2 Conjunctival Chemosis
- •2.16.1.3 Hypotony
- •2.16.1.4 Endophthalmitis
- •2.16.2 Postoperative Retinal Break Formation
- •2.17 Advantages and Disadvantages of 23 and 25 G Systems
- •2.18 Combined Cataract Extraction and PPV
- •2.18.1 How to Decide Whether to Perform Combined Surgery
- •2.18.1.1 Accommodation
- •2.19 Biometry
- •2.20 Chandelier Systems and Bimanual Surgery
- •2.20.1 Possible Complications
- •2.21 Dyes
- •2.22 Intravitreal Injections
- •2.22.1 Injection Medications
- •2.23 Slow Release Preparations
- •2.24 Summary
- •References
- •3: Principles of Internal Tamponade
- •3.1 Gases
- •3.1.1 Principles
- •3.1.1.1 Properties
- •3.1.1.2 A Safe Method for Drawing Up Gas
- •3.1.2 Complications
- •3.1.2.1 Vision
- •3.1.2.2 Refraction
- •3.1.2.3 Cataract
- •3.1.2.5 Loss of the Gas Bubble
- •3.1.2.6 Gas in the Wrong Place
- •3.1.3 Important Postoperative Information
- •3.1.3.1 Flying or Travel to High Altitude
- •3.1.3.2 General Anaesthesia
- •3.2 Silicone Oil
- •3.2.1 Properties
- •3.2.3 Complications of Silicone Oil
- •3.2.3.1 Refractive Changes
- •3.2.3.2 Cataract
- •3.2.3.5 Cornea
- •3.2.3.6 Macular Toxicity
- •3.2.3.7 Oil in the Wrong Place
- •3.2.3.8 Emulsion
- •3.2.3.9 IOLs
- •3.2.4 Silicone Oil Removal
- •3.2.4.1 Alternative Methods
- •3.2.4.2 Retinal Redetachment Rates After Oil Removal
- •3.2.5 Heavy Silicone Oils
- •3.2.6 Heavy Liquids
- •3.2.7 ‘Light’ Heavy Liquids
- •3.3 Summary
- •References
- •4: Posterior Vitreous Detachment
- •4.1 Introduction
- •4.1.1 Symptoms
- •4.1.1.1 Floaters
- •4.1.1.2 Flashes
- •Introduction
- •Clinical Characteristics
- •4.1.2 Signs
- •4.1.2.1 Detection of PVD
- •4.1.2.2 Shafer’s Sign
- •4.1.2.3 Vitreous Haemorrhage
- •4.1.2.4 Ophthalmoscopy
- •4.1.3 Retinal Tears
- •4.1.3.1 U Tears
- •4.1.3.2 Atrophic Round Holes
- •4.1.3.3 Other Breaks
- •4.1.3.4 Progression to Retinal Detachment
- •4.1.4 Peripheral Retinal Degenerations
- •4.2 Summary
- •References
- •5: Vitreous Haemorrhage
- •5.1 Introduction
- •5.2 Aetiology
- •5.3 Natural History
- •5.4 Erythroclastic Glaucoma
- •5.5 Investigation
- •5.6 Ultrasound
- •5.7 Management
- •5.8 Surgery
- •5.9 Vitrectomy
- •5.10 Summary
- •References
- •6: Rhegmatogenous Retinal Detachment
- •6.1 Introduction
- •6.1.1 Tears with Posterior Vitreous Detachment
- •6.1.2 Breaks Without Posterior Vitreous Detachment
- •6.1.3 Natural History
- •6.1.3.1 Chronic RRD
- •6.1.3.2 Risk to the Other Eye
- •6.2 Clinical Features
- •6.2.1 Anterior Segment Signs
- •6.2.2 Signs in the Vitreous
- •6.2.3 Subretinal Fluid Accumulation
- •6.2.4 Retinal Break Patterns in RRD
- •6.2.5 Macula Off or On
- •6.3 Surgery
- •6.3.1 Flat Retinal Breaks
- •6.3.1.1 Retinopexy
- •6.3.1.2 Cryotherapy
- •6.3.1.3 Cryotherapy in the Clinic Setting
- •6.3.1.4 Laser
- •6.3.1.5 Laser in the Clinic Setting
- •6.3.2 Retinal Detachment
- •6.3.2.1 Principles
- •6.3.2.2 Break Closure
- •6.3.2.3 Relief of Traction
- •6.3.2.4 Alteration of Fluid Currents
- •6.3.2.5 Retinopexy
- •6.3.3 Pars Plana Vitrectomy
- •6.3.3.1 Introduction
- •6.3.3.2 Finding the Breaks
- •6.3.3.4 Draining Subretinal Fluid
- •6.3.3.5 When to Use Heavy Liquids
- •6.3.3.6 Removal of Heavy Liquid
- •6.3.3.7 Choice of Tamponade
- •6.3.3.8 Avoiding Retinal Folds
- •6.3.3.9 Inferior Breaks
- •6.3.3.10 Posterior Breaks
- •6.3.3.11 Multiple Breaks
- •6.3.3.12 Medial Opacities
- •6.3.3.13 Complications
- •6.3.3.14 Surgery for Eyes with No Breaks Found
- •6.3.3.15 Use of 360° Laser or Routine 360° Encirclage
- •6.3.3.16 Posturing
- •6.3.4.1 Operative Stages
- •6.3.4.2 Postoperative Care
- •6.3.4.3 Complications
- •6.3.4.4 Peroperative
- •6.3.4.5 Postoperative
- •6.3.5 Drainage Air Cryotherapy and Explant (DACE)
- •6.3.5.1 Subretinal Fluid (SRF) Drainage
- •6.3.5.2 Air Insertion
- •6.3.5.3 Complications
- •6.3.6 Pneumatic Retinopexy
- •6.3.6.1 Surgical Steps
- •6.3.6.2 Complications
- •6.4 Success Rates
- •6.5 Causes of Failure
- •6.6 Surgery for Redetachment
- •6.7 Secondary Macular Holes
- •6.8 Detachment with Choroidal Effusions
- •6.9 Removal of Explant
- •6.9.1 Diplopia
- •6.9.2 Erosion Through Conjunctiva
- •6.9.3 Infection
- •6.9.4 Cosmesis
- •6.9.5 Irritation
- •6.9.6 Surgery for Removal of the Explant
- •6.10 Summary
- •References
- •7.2 Atrophic Hole RRD with Attached Vitreous
- •7.3 Pseudophakic RRD
- •7.4 Aphakic RRD
- •7.5 Retinal Dialysis
- •7.5.1 Clinical Features
- •7.5.2 Surgery for Retinal Dialysis
- •7.5.2.1 Search
- •7.5.2.2 Cryotherapy
- •7.5.2.3 Marking the Break
- •7.5.2.4 Plombage
- •7.5.2.5 Checking the Indent
- •7.5.3 Complications
- •7.5.4 Giant Retinal Dialysis
- •7.5.5 Dialysis and PVR
- •7.5.6 Par Ciliaris Tear
- •7.6 Giant Retinal Tear
- •7.6.1 Clinical Features
- •7.6.2 Stickler’s Syndrome
- •7.6.3 Surgery for Giant Retinal Tear
- •7.6.3.1 Heavy Liquids
- •7.6.3.2 Retinopexy
- •7.6.3.3 Trans-scleral Illumination Technique
- •7.6.3.4 Silicone Oil Insertion
- •7.6.3.5 Choice of Endotamponade
- •7.6.3.6 Success Rates
- •7.6.3.7 Removal of the Silicone Oil
- •7.6.3.8 The Other Eye
- •7.7 Retinal Detachment in High Myopes
- •7.7.1 Clinical Features
- •7.7.2 Surgery
- •7.8.1 Clinical Features
- •7.8.1.1 Infantile Retinoschisis
- •7.8.1.2 Senile Retinoschisis
- •7.8.1.4 Retinal Detachment in Retinoschisis
- •7.8.2 Surgery
- •7.9 Juvenile Retinal Detachment
- •7.10 Atopic Dermatitis
- •7.11 Refractive Surgery
- •7.12 Congenital Cataract
- •7.13 Others
- •7.14 Summary
- •References
- •8: Proliferative Vitreoretinopathy
- •8.1 Introduction
- •8.2 Pathogenesis
- •8.3 Clinical Features
- •8.3.1 Introduction
- •8.3.2 Grading
- •8.3.3 Risk of PVR
- •8.4 Surgery
- •8.4.1 Mild PVR
- •8.4.2 Moderate PVR
- •8.4.3 Severe PVR
- •8.4.3.1 The Relieving Retinectomy
- •8.4.4 Radial Retinotomy
- •8.4.5 Silicone Oil Injection
- •8.4.6 Applying Laser
- •8.4.7 ROSO Plus
- •8.4.8 Very Severe PVR
- •8.4.9 Choice of Endotamponade
- •8.4.9.1 Silicone Oil or Perfluoropropane Gas
- •8.4.9.2 Heavy Oils
- •8.4.10 Removal of Subretinal Bands
- •8.4.11 Adjunctive Therapies
- •8.4.12 Success Rates
- •8.4.13 Postoperative Complications
- •8.5 Summary
- •References
- •9: Macular Hole
- •9.1 Introduction
- •9.2 Idiopathic Macular Hole
- •9.2.1 Clinical Features
- •9.2.1.1 Introduction
- •9.2.1.2 Watzke–Allen Test
- •9.2.1.3 Grading
- •9.2.1.4 Natural History
- •9.2.1.5 Optical Coherence Tomography
- •9.2.2 Secondary Macular Holes
- •9.2.3 Lamellar and Partial Thickness Holes
- •9.2.4 Surgery
- •9.2.4.1 Introduction
- •9.2.4.2 Surgery
- •9.2.4.3 Peeling the Posterior Hyaloid Membrane
- •9.2.4.4 ILM Peel and Other Adjunctive Therapies
- •9.2.4.5 Choice of Tamponade
- •9.2.4.6 Postoperative Posturing of the Patient
- •9.2.4.9 Visual Field Loss
- •9.2.5 Success Rates
- •9.2.6 Reoperation
- •9.3 Microplasmin
- •9.4 Summary
- •References
- •10.1 Clinical Features
- •10.1.1 Other Conditions
- •10.1.2 Secondary Macular Pucker
- •10.2 Surgery
- •10.3 Success Rates
- •10.5 Membrane Recurrence
- •10.6 Summary
- •References
- •11: Choroidal Neovascular Membrane
- •11.1 Age-Related Macular Degeneration
- •11.1.1 Clinical Features
- •11.1.2 Vitreous Haemorrhage and CNV
- •11.1.3 Pneumatic Displacement of Subretinal Haemorrhage
- •11.1.4 Surgery for Failed Anti-VEGF Therapy
- •11.1.4.1 Introduction
- •11.1.4.2 360° Macular Translocation
- •11.1.6 Success Rates
- •11.2 Choroidal Neovascular Membrane Not from ARMD
- •11.2.1 Introduction
- •11.2.2 Surgery
- •11.3 Summary
- •References
- •12: Diabetic Retinopathy
- •12.1 Introduction
- •12.2 Diabetic Retinopathy
- •12.2.1 Introduction
- •12.2.1.1 Diabetic Retinopathy Grading
- •12.2.2 Diabetic Vitreous Haemorrhage
- •12.2.3 Progression to Vitreous Haemorrhage and Tractional Retinal Detachment
- •12.2.3.1 Clinical Features
- •12.2.3.2 Surgery
- •12.2.4 Diabetic Retinal Detachment
- •12.2.4.1 Clinical Features
- •12.2.4.2 Surgery
- •12.2.4.3 Tractional Retinal Detachment
- •12.2.4.4 Peroperative Panretinal Photocoagulation
- •12.2.4.6 Bimanual Surgery
- •12.2.4.7 Dealing with Bleeding Vessels
- •12.2.4.8 Iatrogenic Breaks
- •12.2.4.9 Silicone Oil
- •12.2.4.10 Combined TRD and RRD
- •12.2.5 Postoperative Complications
- •12.2.5.1 Vitreous Haemorrhage
- •12.2.5.2 Rhegmatogenous Retinal Detachment
- •12.2.5.3 Iris Neovascularisation
- •12.2.5.4 Phthisis Bulbi
- •12.2.5.5 Maculopathy
- •12.2.5.6 Survival After Surgery
- •12.2.6 Success Rates
- •12.2.7 Diabetic Maculopathy
- •References
- •13: Other Vascular Disorders
- •13.1 Introduction
- •13.2 Retinal Vein Occlusion
- •13.2.1 Chorioretinal Anastomosis
- •13.2.2 Arteriovenous Decompression
- •13.2.3 Radial Optic Neurotomy
- •13.2.4 Intravitreal Steroid and Anti-VEGF Agents
- •13.2.5 Tissue Plasminogen Activator
- •13.3 Sickle-Cell Disease
- •13.3.1 Introduction
- •13.3.2 Types of Sickle-Cell Disease
- •13.3.3 Systemic Investigation
- •13.3.4 Inheritance and Race
- •13.3.5 Systemic Manifestations
- •13.3.6 Ophthalmic Presentation
- •13.3.7 Laser Therapy
- •13.3.8 Surgery
- •13.3.9 Visual Outcome
- •13.3.10 Screening
- •13.3.11 Survival
- •13.4 Retinal Vasculitis
- •13.5 Central Retinal Artery Occlusion
- •13.6 Summary
- •References
- •14: Trauma
- •14.1 Introduction
- •14.3 Contusion Injuries
- •14.3.1 Clinical Presentation
- •14.3.2 Types of Retinal Break
- •14.3.2.1 Dialysis
- •14.3.2.2 Pars Ciliaris Tears
- •14.3.2.3 Ragged Tear in Commotio Retinae
- •14.3.2.4 Giant Retinal Tears
- •14.3.3 Surgery
- •14.3.4 Visual Outcome
- •14.4 Rupture
- •14.4.1 Clinical Presentation
- •14.4.2 Surgery
- •14.4.3 Visual Outcome
- •14.5 Penetrating Injury
- •14.5.1 Clinical Presentation
- •14.5.1.1 Endophthalmitis
- •14.5.1.2 Retinal Detachment
- •14.5.2 Surgery
- •14.5.3 Visual Outcome
- •14.6 Trauma Scores
- •14.7 Intraocular Foreign Bodies
- •14.7.1 Clinical Presentation
- •14.7.1.1 Diagnostic Imaging
- •14.7.2 IOFB Materials
- •14.7.3 Surgery
- •14.7.4 The Primary Procedure
- •14.7.5 PPV: The Anterior Segment
- •14.7.5.1 The Lens
- •14.7.6 PPV: The Posterior Segment
- •14.7.7 The Magnet
- •14.7.8 Visual Outcome
- •14.7.9 Siderosis
- •14.8 Perforating Injury
- •14.9 Sympathetic Ophthalmia
- •14.10 Proliferative Vitreoretinopathy
- •14.11 Phthisis Bulbi
- •14.12 When Not to Operate
- •14.12.1 At Presentation
- •14.12.2 Postoperatively
- •14.13 Summary
- •References
- •15.1 Introduction
- •15.2 Dropped Nucleus
- •15.2.1 Clinical Features
- •15.2.2 Surgery
- •15.2.2.1 Primary Management
- •15.2.2.2 Vitrectomy Surgery
- •15.2.2.4 Success Rates
- •15.3 Intraocular Lens Dislocations
- •15.3.1 Clinical Presentation
- •15.3.2 Surgery
- •15.3.2.1 Removal of the IOL
- •15.4 Surgical Options for the Aphakic Eye
- •15.4.1 McCannell Sutured IOL
- •15.4.2 Iris-Clip IOL
- •15.4.3 Haptic Capture Method
- •15.4.4 Anterior Chamber IOL
- •15.4.5 Sutured Posterior Chamber IOLs
- •15.4.6 The Aphakic and Aniridic Eye
- •15.5 Postoperative Endophthalmitis
- •15.5.1 Clinical Features
- •15.5.2 Surgery
- •15.5.2.1 Vitreous Tap
- •15.5.2.2 Vitreous Biopsy
- •15.5.3 Infective Organisms
- •15.5.4 Antibiotics
- •15.5.5 The Role of Vitrectomy
- •15.5.6 Success Rates
- •15.6 Chronic Postoperative Endophthalmitis
- •15.7 Needlestick Injury
- •15.7.1 Clinical Features
- •15.7.2 Surgery
- •15.8 Intraocular Haemorrhage
- •15.9 Retinal Detachment
- •15.10 Chronic Uveitis
- •15.11 Postoperative Cystoid Macular Oedema
- •15.12 Postoperative Vitreomacular Traction
- •15.13 Postoperative Choroidal Effusion
- •15.13.1 External Drainage
- •15.14 Summary
- •References
- •16: Uveitis and Allied Disorders
- •16.1 Introduction
- •16.2 Non-infectious Uveitis of the Posterior Segment
- •16.2.2 Retinal Detachment
- •16.2.3 Cystoid Macular Oedema
- •16.2.4 Hypotony
- •16.2.5 The Vitreous Biopsy
- •16.2.6 Sampling at the Beginning of a PPV
- •16.2.6.1 Special Situations
- •16.3 Acute Retinal Necrosis
- •16.3.1 Clinical Features
- •16.3.2 Surgery
- •16.3.2.1 For Diagnosis
- •16.3.2.2 For Treatment
- •16.3.3 Visual Outcome
- •16.4 Cytomegalovirus Retinitis
- •16.4.1 Clinical Features
- •16.4.2 Surgery
- •16.4.2.1 For Diagnosis
- •16.4.2.2 For Treatment
- •16.4.3 Visual Outcome
- •16.5 Fungal Endophthalmitis
- •16.5.1 Clinical Features
- •16.5.2 Surgery
- •16.5.2.1 For Diagnosis
- •16.5.2.2 For Treatment
- •16.5.3 Visual Outcome
- •16.6 Other Infections
- •16.6.1 Clinical Features
- •16.6.2 Surgery
- •16.6.2.1 For Diagnosis
- •16.6.2.2 Chorioretinal Biopsy
- •16.6.2.3 For Treatment
- •16.6.3 Visual Outcome and Survival
- •16.7 Paraneoplastic Retinopathy
- •16.8 Summary
- •References
- •17: Miscellaneous Conditions
- •17.1 Vitrectomy for Vitreous Opacities
- •17.2 Vitreous Anomalies
- •17.2.1 Persistent Hyperplastic Primary Vitreous
- •17.2.2 Asteroid Hyalosis
- •17.2.3 Amyloidosis
- •17.3 Retinal Haemangioma and Telangiectasia
- •17.4 Optic Disc Anomalies
- •17.4.1 Optic Disc Pits and Optic Disc Coloboma
- •17.4.2 Morning Glory Syndrome
- •17.5 Retinochoroidal Coloboma
- •17.6 Marfan’s Syndrome
- •17.7 Retinopathy of Prematurity
- •17.8 Uveal Effusion Syndrome
- •17.8.1 Clinical Features
- •17.8.2 Surgery
- •17.9 Terson’s Syndrome
- •17.10 Disseminated Intravascular Coagulation
- •17.11 Retinal Prosthesis
- •17.12 Summary
- •References
- •Glossary of Abbreviations
- •Others in Database
- •Appendices
- •Useful Formulae and Rules
- •Cryotherapy
- •Fluids (i.e. Both Gases and Liquids)
- •Gases
- •Liquids
- •Ultrasound
- •Diffusion and Viscosity
- •Visual Acuity
- •Diffusion
- •Fick’s Law
- •Stokes-Einstein
- •Darcy’s Law
- •Starling’s Law
- •Index
2.3 Pars Plana Vitrectomy |
25 |
|
|
Fig. 2.6 Check that the infusion is inserted properly before turning on the ßuid, a metallic glint must be seen
Surgical Tip
Subconsciously, the surgeon uses the force of the instruments on the sclerotomies to move the eye around to aid visualisation of the different parts of the retina when operating, for example, to move a slightly depressed eye superiorly to allow direct viewing of the macula or to move the eye superiorly to see the superior retina. Placing the sclerotomies too close to the horizontal creates difÞculty with manipulation of the eye in this way.
Wash the eye with balanced salt solution to clear any blot clots and apply hydroxymethylcellulose (HPMC) to the cornea.
Note: During 20 G surgery, insert the light pipe Þrst (usually, this is easy to insert) because the internal illumination shows up the second sclerotomy as an orange spot in the darkened room. In contrast, during 23 G surgery, insert the light pipe second using its illumination to Þnd the exterior portion of the trochar for insertion of the instrument, for example, cutter.
2.3.5How to Clear the End of Non-penetrating
Infusion Cannula |
2.3.7 Checking the View |
In an aphake or pseudophake, make the superonasal sclerotomy with the micro vitreoretinal blade (MVR), or cutter tip with small gauge, and push the MVR tip against the end of the cannula to clear the choroid away. In a phakic patient, insert the vitreous cutter and remove some of the vitreous whilst pressing the infusion cannula into the eye to allow apposition of the cutter tip to the cannula without touching the lens. This allows clearance of the choroid by scraping the cannula tip onto the cutter. Turn the infusion on before releasing the indentation of the cannula:
1. To allow the pressure to rise in a controlled fashion.
2. To prevent movement of the infusion tip back under the choroid before the ßow of ßuid has commenced.
2.3.6The Superior Sclerotomies
2.3.6.1 Where to Place
Incise the two superior sclerotomies, one in the superotemporal quadrant and one in the superonasal quadrant. Place these approximately 150¡ apart. If the sclerotomies are too close together, they will force the surgeonÕs hands close together and reduce manoeuvrability. Too far apart and the movement of the eye becomes difÞcult. In particular, when one sclerotomy is being used during indentation, a sclerotomy on the horizontal will tend to cause circumferential rotation of the eye instead of a movement in the superior to inferior plane.
Insert the light pipe into one sclerotomy, rotate in the indirect viewing system (IVS) and dim the room lights. With the BIOM system, set the focus wheel to ¼ from the top of its range of adjustment. Invert the image (a stereo image inverter is required), and use the XY control of the microscope to obtain a red reßex in the lens. Increase the magniÞcation to higher than is anticipated during the surgery, and focus onto the optic disc by adjusting the IVS lens.
Note: Using high magniÞcation at this stage ensures that the focus at lower magniÞcations is maintained for later in the operation. Time is not wasted later by refocusing during crucial manoeuvres in the operation.
Lower the IVS lens until it reaches the lowest point that the optic disc remains in focus. This results in a focal range which is anterior to the optic disc and will allow a focussed image from the disc to the ora serrata throughout surgery in all but highly myopic eyes. There is no point in the focal plane existing posterior to the disc, that is, into the invisible tissue in the orbit!
2.3.8The Independent Viewing System
1. To focus anteriorly, the IVS lens goes down, and to focus posteriorly, the lens goes up.
2. The IVS is easier to use when it is further away from the cornea.
3. The Þeld of view is increased when the lens is closer to the cornea.
26 |
2 Introduction to Vitreoretinal Surgery |
|
|
The assistant should use a straight bore cannula to irrigate the cornea to help avoid splashing the lens or preferably place HPMC onto the cornea which requires less frequent application and helps keep the corneal epithelium healthy.
There are now a number of IVS systems. The Eibos is compact and easy to focus with a Þngertip during surgery but provides a smaller Þeld of view than the BIOM (Oculus). It is covered with a sterilised sleeve and so requires only one system per operating theatre. The BIOM is sterilised in total requiring at least two or three systems per theatre. It is more difÞcult to focus peroperatively unless a motorised unit is purchased. The view is however superior and is therefore the system favoured by this surgeon. The Zeiss system has an even wider Þeld of view and a useful focussing system in the +2D objective lens. Most come with a wide angle lens for peripheral retina and a high magniÞcation lens for the macula. The IVS provides reduced depth perception compared with contact lenses which can be helpful for macular membrane peels.
Surgical Pearl of Wisdom
Getting the BIOM Focussed
When operating, having a good view is essential. Start with the BIOM indirect viewing system well focussed.
When you start your surgery, make sure the microscope is centred on neutral and focussed on neutral. Take the BIOMR and use the turn screw to get the lower lens as high up as possible. Put the BIOMR in place. This usually gives a small blurry view of the retina. Try to Þnd a blood vessel or the disc, and use the turn screw to lower the lens so the disc/vessel is in focus. At this point, use the Ôfocus downÕ pedal on the microscope to enlarge the Þeld of view. Make sure you look past the microscope at the eye and not through the microscope as you enlarge the Þeld of view, so as not to inadvertently hit the eye.
Sarit Lesnik Oberstein, Dept of Ophthalmology, University of Amsterdam, Amsterdam, The Netherlands
enough to have a full Þeld again. That gives maximum intraocular Þeld. (Unfortunately, with some lenses and systems, there can be corneal lens contact before the grey patch can be seen.)
Second, it is important to roll the eye as far as you can using both the cutter and light pipe; this involves quite a push. One then Ôcatches upÕ with the wide angle viewing system using the XY shift on the microscope. I Þnd most trainees roll the eye into a position that matches the wide angle viewing system, not the other way around. Third, rolling the eye results in it sinking in the orbit; to compensate, the microscope needs to be lowered further in order to recapture lost Þeld. The reverse of this is that you have to retract the microscope when rolling the eye back to the primary position.
Practising these results in a better view and faster, better surgery.
D. Alistair H. Laidlaw, Dept of Ophthalmology, St Thomas Hospital, London, UK
Surgical Pearl of Wisdom
Optimum use of noncontact wide angle viewing systems such as the Oculus BIOM, Topcon Resight or Volk Merlin can make a massive difference to the peripheral vitrectomy. I have no experience of using the Eibos system so I do not know if the same advice applies. There are three principals, but the process is iterative and involves all four limbs at once, a bit like ßying a helicopter! I am assuming that the lens is correctly focussed.
First, the lens must be close enough to the eye. Ensure that the edge of the iris cannot be seen in the surgeons view; if anything other than an iris edge is visible, the lens is not close enough. For Þne tuning then, move the suspended lens down further until a grey patch appears in your view; then, back off just
Fig. 2.7 The IVS (in this case, a BIOM system) is attached to the microscope allowing visualisation of the posterior segment without a contact lens
2.3 Pars Plana Vitrectomy |
27 |
|
|
Fig. 2.8 When visualising an image in the centre of the vitreous cavity, a neutral distance of the IVS from the microscope is utilised. On a BIOM system, this is approximately one-quarter down from its highest point. To focus more posteriorly, move the objective lens closer to the microscope as the rays of light from a more posterior image become more convergent through the lens and are focussed closer to the objective lens. Conversely, to focus more anteriorly, for example, during the search for retinal tears at the end of a vitrectomy procedure, move the objective lens further away from the microscope, as the rays of a near object are more divergent and are focussed further away from the objective lens, horizontal green arrows = image inversion, vertical red arrows indicate direction of movement of the lenses
Fig. 2.9 When Þnding the optimal focal range for use at the beginning |
|
|
of the operation, increase the magniÞcation of vision and focus on the |
|
|
disc. Increasing the magniÞcation in this way ensures that there is a Þne |
|
|
focus on the back of the eye. Because there is a focal range for the lens |
|
|
system (analogous to that used in photography), employ this focal range |
|
|
during the surgery. With the focal range in the midposition, it is possible |
|
|
to focus in the mid vitreous without the disadvantage of focal range |
|
|
going into the invisible tissues of the orbit behind the eye. By moving the |
|
|
objective lens further away from the microscope, until focus is just |
|
|
retained in the posterior pole or the optic disc, a focal range going from |
|
|
the optic disc, anteriorly to as far as the ora serrata, is possible in most |
|
|
eyes. This will allow visualisation of the whole retina throughout the |
|
|
surgery without having to refocus or readjust the lens. This manoeuvre |
|
|
at the beginning of the operation will save time later on avoiding read- |
|
|
justing focus throughout points of the surgery where delay is not advan- |
|
|
tageous. On the other hand, focusing onto the optic disc with the objective |
|
|
lens too close to the microscope will only allow focus on the optic disc |
|
|
and the rest of the focal range will be going into the orbit, forcing you to |
|
|
refocus during surgery, vertical red arrows indicate direction of move- |
Focal range |
|
ment of the lenses |
||
|
Fig. 2.10 In a highly myopic eye, it may not be possible to bring the virtual image into focus when the +2 lens is inserted between the microscope and the objective lens. Only by removing this lens will the focal range for the system to allow visualisation of the image, vertical red arrows indicate direction of movement of the lenses
28 |
2 Introduction to Vitreoretinal Surgery |
|
|
Fig. 2.11 The reduced refractive index of air causes a myopic shift on the back of an intraocular lens or phakic lens by producing convergence of the rays of light from an image, thereby, producing an image closer to the objective lens of the IVS. Therefore, the lens needs to be elevated relative to the microscope to overcome this and retain focus, vertical red arrows indicate direction of movement of the lenses
Fig. 2.13 A typical vitreous detached from the back of the eye but still attached at the vitreous base
Fig. 2.12 The loss of the intraocular lens causes light to diverge from the eye. The virtual image then is further away from the objective lens, and the lens needs to be moved further away from the microscope to retain focus. When air is inserted, having contact either with the cornea or bulging through the pupil, the light diverges further and the vitreal image is then further away from the objective lens and there must be more distance produced between the objective lens and the microscope, vertical red arrows indicate direction of movement of the lenses
2.3.9Removing the Vitreous
Keep the Þngers light on the instruments to ease any tension and to improve manoeuvrability. Use the wrist rests. The surgeon can apply forces to the sclerotomies via the instrument shafts to rotate and manoeuvre the globe into position for maximal visualisation of the peripheral retina (a technique which is lost with the use of some ßexible small gauge instruments). The light pipe shines onto the active instrument or behind it to retroilluminate.
Note: Be aware of where the light pipe is in the eye. Ignoring the position of the light pipe is a common reason for touching the lens. Also, any drift into the eye could result in a macular injury because the instruments are pointing at the macula.
As with any surgery, perform the easiest moves Þrst so that if a complication arises from a difÞcult part of the operation, the effects on subsequent manoeuvres are minimised. Therefore, when removing the vitreous, excise centrally Þrst to clear some space in the vitreous cavity. Keep the cutter oriÞce in view during the vitreous clearance but also angled towards the vitreous you are removing. Then take the ÔeasyÕ vitreous on the same side of the eye as the cutter and away from any hazards, for example, a bullous retinal detachment. Finally, remove vitreous from the hazardous areas.
The vitreous cutter should be moved only minimally in the eye. Try keeping it in one place letting the vitreous come to the tip, which the gel will do especially if it is detached. Remember the vitreous is anchored at the vitreous base so that just posteriorly to the base is a good place to have the cutter tip. Work around the periphery systematically so that the same areas are not gone over twice. In a phakic eye, you may proceed from 2 to 6 oÕclock. Change the instruments over to the opposite hands (a good vitreoretinal surgeon is able to use both hands with ease), and do the other side from 10 to 6 oÕclock. The 2 to 10 oÕclock vitreous can be taken from either side.
Note: Think of the space around the periphery of the lens as a circular channel in which it is safe to pass instruments. The walls of the channel are the posterior bulge of the lens and the pars plana.
This avoids the risk of a Ôlens touchÕ which is an indentation on the posterior capsule and cortex of the lens from contact
2.3 Pars Plana Vitrectomy |
29 |
|
|
Fig. 2.14 At the commencement of the PPV, remove the central vitreous to create space for the instruments
Fig. 2.15 Gradually work towards the peripheral gel, then remove this as close to the vitreous base as possible
with the shaft of an instrument (in pseudophakic and aphakic eyes you do not need to change hands). Keep away from the back of the lens by passing the cutter around the periphery and letting the vitreous come anteriorly towards the tip. Be aware of the position of the light pipe; it is too easy only to concentrate on the cutter and forget about the light pipe.
Note: Avoid a ÔlazyÕ right foot, that is, make sure you actively use the XY control of the microscope to maximise your view during the surgery.
A
Lens
Lens
Fig. 2.16 The surgeon can go more anteriorly in the circular ÔchannelÕ around the periphery of the lens than is possible across the posterior of the lens. Therefore, from sclerotomy (A), instruments can be safely passed across the periphery of the lens (blue arrows) but not across the middle (red arrow)
You should become good enough that the maximum vacuum and cut rates are used throughout (Ôleft foot ßat to the ßoorÕ); slower vacuum is only required when close to mobile and detached retina.
Remember, in eyes with attached gel (e.g. macular holes, see Chap. 8), you will need to induce a vitreous detachment, and often these eyes have more vitreous volume to remove (therefore, more time is required for vitreous removal) than an eye with a shrunken detached gel (e.g. rhegmatogenous retinal detachment). Take as much vitreous as possible especially at the sclerotomies and the infusion site to minimise the chance of problems such as:
1.Vitreous incarceration into sclerotomies or the infusion cannula which precedes retinal incarceration. Too much vitreous left around the sclerotomies allows the vitreous to be drawn into the sclerotomy by the ßow of infusion ßuid. This causes traction on the retina and can pull retina into the sclerotomy especially if the retina is detached near the sclerotomy.
2.Non-penetration of instruments through the vitreous base during insertion running a risk of giant retinal tear. By pushing the vitreous base into the centre of the eye, the traction on the retina can tear the retina causing a giant retinal tear.
3.Clogging of ßute needles during aspiration procedures, for example, when draining subretinal ßuid from a retinal break. If too much vitreous is left near a retinal break, it enters the ßute needle preventing SRF drainage. Excise the vitreous with the cutter and continue the drainage with the cutter or the ßute.
4.Minimising the risk of postoperative entry site breaks. Incarcerated vitreous in the sclerotomies may gradually contract causing retinal traction and retinal break formation postoperatively.
The next stage is to perform the vitreoretinal procedures
explained elsewhere in the appropriate chapters.
